insights_auto
Why is CUV down 2.77%?
Dive Deeperchevron_right
CUV:ASX
Clinuvel Pharmaceuticals Ltd
A$7.38
arrow_downward
-2.77%(-0.21) 1D
Nov 17, 4:10:06โฏPM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CUV...
Open
A$7.46
High
A$7.51
Low
A$7.36
Mkt. cap
372.59M
Avg. vol.
158.10K
Volume
98.54K
Dividend
0.68%
Quarterly dividend
A$0.01
Ex-dividend date
Sep 3, 2026
P/E ratio
11.05
52-wk high
A$13.48
52-wk low
A$6.62
EPS
A$0.67
Shares outstanding
50.49M
No. of employees
16
Open
A$7.46
High
A$7.51
Low
A$7.36
Mkt. cap
372.59M
Avg. vol.
158.10K
Volume
98.54K
Dividend
0.68%
Quarterly dividend
A$0.01
Ex-dividend date
Sep 3, 2026
P/E ratio
11.05
52-wk high
A$13.48
52-wk low
A$6.62
EPS
A$0.67
Shares outstanding
50.49M
No. of employees
16
News stories
From web sources and news partners
ChartMill
·
1 hour ago
S&P 500 Stocks Gapping Down in Today's Session
Benzinga
·
15 minutes ago
Walmart Stock Posts Best 2-Month Run Vs. S&P 500 Since 1975 - Walmart (NASDAQ:WMT)
TradingView
·
2 hours ago
Wells Fargo sets 2027 S&P 500 year-end target at 8,200
Traders Union
·
41 minutes ago
S&P 500 trades near AVWAP and key retracement lines, Chris Ciovacco notes
About Clinuvel Pharmaceuticals Ltd
CEOPhilippe J. Wolgen
Employees16
Founded1987
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteclinuvel.com